Fig. 2From: Survival differences between patients with de novo and relapsed/progressed advanced non-small cell lung cancer without epidermal growth factor receptor mutations or anaplastic lymphoma kinase rearrangementsTime to (A) first and (B) second subsequent therapy or death in de novo and relapsed/progressed advanced non-small cell lung cancer CI, confidence intervalBack to article page